首页> 外国专利> FIXED DOSE COMBINATION DRUG COMPOSITION COMPRISING LOSARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE

FIXED DOSE COMBINATION DRUG COMPOSITION COMPRISING LOSARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE

机译:包含洛沙坦,吗啡和氢氯噻嗪的固定剂量组合药物组合物

摘要

PURPOSE: A fixed dose combination drug composition containing losartan, amlodipine, and hydrochlorothiazide is provided to minimize single formulation and composite, to ensure excellent elution rate, and to prevent or treat cardiovascular diseases. CONSTITUTION: A fixed dose combination drug composition for preventing or treating cardiovascular diseases contains losartan or pharmaceutically acceptable salt thereof, amlodipine or pharmaceutically acceptable salt thereof; and hydrochlorothiazide. The composition additionally contains crospovidone, starch sodium glyconate, croscarmellose sodium, low substitution hydroxypropyl cellulose or a mixture thereof in a first layer as a disintegrant. [Reference numerals] (AA) Composite layer of amlodipine and hydrochlorothiazide; (BB) Rozatan layer
机译:目的:提供包含氯沙坦,氨氯地平和氢氯噻嗪的固定剂量组合药物组合物,以最大程度地减少单一制剂和复合物,确保出色的洗脱率,并预防或治疗心血管疾病。组成:用于预防或治疗心血管疾病的固定剂量组合药物组合物,包含氯沙坦或其可药用盐,氨氯地平或其可药用盐;和氢氯噻嗪。该组合物在第一层中还包含交联维酮,淀粉葡糖酸钠,交联羧甲基纤维素钠,低取代羟丙基纤维素或其混合物作为崩解剂。 [附图标记](AA)氨氯地平和氢氯噻嗪的复合层; (BB)罗扎坦层

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号